A Randomized, Active-Control, Pilot Trial of Front-Loaded Dosing Regimens of Darbepoetin-Alfa for the Treatment of Patients with Anemia during Chemotherapy for Malignant Disease [1] (multiple letters)

Cancer

Volumn 100, Issue 7, 2004, Pages 1545-1546

  Waltzman, Roger J ^a,b,c   Glaspy, John ^d   Rossi, Greg ^b  

^a Ortho Biotech Products LP   (United States)

^b AMGEN INC   (United States)

^c ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ANEMIA; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; LETTER; MAINTENANCE THERAPY; MALIGNANT NEOPLASTIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOETIN ALFA; ERYTHROPOIETIN; HEMATINICS; HUMANS; NEOPLASMS;

EID: 1642312996     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20116     Document Type: Letter

References (0)